<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7331074\results\search\disease\results.xml">
  <result pre="pmcid: 7331074 doi: 10.1021/acsomega.0c01545 : Article Quantitative Proteomics Analysis of" exact="Systemic" post="Responses and Biological Mechanisms of ShuFengJieDu Capsule Using H1N1-Infected"/>
  <result pre="+86-2077-8073. *Email: luhongzhou@fudan.edu.cn. Fax: +86-2077-8881. epub: 2020-06-06collection: 2020-06-065251541715423received: 2020-04-05accepted: 2020-06-02(C)" exact="American" post="Chemical Society, 2020This is an open access article published"/>
  <result pre="the article or any adaptations for non-commercial purposes. Abstract Emerging" exact="infectious diseases" post="(EIDs) are a significant burden on global economies and"/>
  <result pre="(abbreviated as SFJD) is a TCM prescription used for treating" exact="upper respiratory infection" post="(URI) with symptoms of fever, sore throat, headaches, nasal"/>
  <result pre="as SFJD) is a TCM prescription used for treating upper" exact="respiratory" post="infection (URI) with symptoms of fever, sore throat, headaches,"/>
  <result pre="SFJD) is a TCM prescription used for treating upper respiratory" exact="infection" post="(URI) with symptoms of fever, sore throat, headaches, nasal"/>
  <result pre="is also widely used for the prevention and treatment of" exact="viral" post="infectious diseases, especially for the EIDs. In this study,"/>
  <result pre="also widely used for the prevention and treatment of viral" exact="infectious diseases," post="especially for the EIDs. In this study, a bioactivity-integrated"/>
  <result pre="of proinflammatory cytokines, the IFN (interferon)-stimulated gene signal in the" exact="Type I" post="IFN, TBK/IRF3, and MAPK/NF-ÎºB signaling pathways. In conclusion, we"/>
  <result pre="bioactive compounds in SFJD exerting antiviral effects and illuminated that" exact="Type I" post="IFN and MAPK/NF-ÎºB signaling pathways are involved in the"/>
  <result pre="IFN and MAPK/NF-ÎºB signaling pathways are involved in the anti-H1N1" exact="infection" post="effects of SFJD. Our study not only provides solid"/>
  <result pre="research methods for TCM study. Introduction Epidemics associated with emerging" exact="infectious diseases" post="(EIDs) are now occurring in historically unprecedented numbers and"/>
  <result pre="efficacy depends on the timing of administration and is often" exact="limited" post="by supply shortage.6 Additionally, mutations of the virus have"/>
  <result pre="property of neuraminidase (NA) for the binding of oseltamivir, making" exact="viral" post="strains become resistant against these drugs.7âˆ’9 Thus, more work"/>
  <result pre="and Radix glycyrrhizae, is one type of TCM for treating" exact="upper respiratory infection" post="(URI) with symptoms of fever, sore throat, headache, and"/>
  <result pre="Radix glycyrrhizae, is one type of TCM for treating upper" exact="respiratory" post="infection (URI) with symptoms of fever, sore throat, headache,"/>
  <result pre="glycyrrhizae, is one type of TCM for treating upper respiratory" exact="infection" post="(URI) with symptoms of fever, sore throat, headache, and"/>
  <result pre="study, we found that the presence of SFJD increased the" exact="partial" post="pressure of oxygen in lung tissue, decreased lactic acid"/>
  <result pre="and inhibited inflammatory factors such as IL-1Î² and TNF-Î± in" exact="acute" post="lung injury rats. However, the underlying mechanisms remain largely"/>
  <result pre="SFJD and uncovered the underlying mechanisms involved in the anti-H1N1" exact="infection" post="effects of SFJD. We assessed the underlying mechanisms of"/>
  <result pre="cytokines, the IFN-stimulated gene expressions,15 and key effectors in the" exact="Type I" post="IFN signaling pathways,16 TBK/IRF3 signaling pathways,17 and MAPK/NF-ÎºB signaling"/>
  <result pre="numbers (aâ€&quot;d) is shown in Figure S1 and Table S1." exact="Protein" post="Profiles Reveal Global Protein Changes in Different Treatment Groups"/>
  <result pre="in Figure S1 and Table S1. Protein Profiles Reveal Global" exact="Protein" post="Changes in Different Treatment Groups in the H1N1-Infected RAW264.7"/>
  <result pre="in the H1N1-Infected RAW264.7 Cells To gain the insight into" exact="systemic" post="responses to H1N1 virus infection in the absence or"/>
  <result pre="Cells To gain the insight into systemic responses to H1N1" exact="virus infection" post="in the absence or presence of forsythoside E, verbenalin,"/>
  <result pre="To gain the insight into systemic responses to H1N1 virus" exact="infection" post="in the absence or presence of forsythoside E, verbenalin,"/>
  <result pre="shown in Figure 3C. Furthermore, based on our dataset, a" exact="total" post="of 33 differentially expressed proteins fell into this â€œantivirus"/>
  <result pre="STAT1, and NF-ÎºBp65 are the key signaling molecules in the" exact="Type I" post="interferons (IFNs).19âˆ’21 To our knowledge, Type I IFNs are"/>
  <result pre="molecules in the Type I interferons (IFNs).19âˆ’21 To our knowledge," exact="Type I" post="IFNs are essential for immune defense against viruses.22 Macrophages"/>
  <result pre="synthesize and release proinflammatory cytokines and IFNs, which further limit" exact="viral" post="replication and spread.23 Intriguingly, single ingredient showed various effects"/>
  <result pre="reveal novel mechanisms of those active ingredients in the H1N1" exact="infection" post="in RAW264.7 cells. (A) Workflow of the iTRAQ approach"/>
  <result pre="related with antivirus and immunoregulation of the three candidate ingredients." exact="Type I" post="IFN-Related Signaling Pathway Analysis in SFJD-Treated H1N1-Infected RAW264.7 Cells"/>
  <result pre="immune mechanism. Through analyzing the abovementioned data, we found that" exact="Type I" post="IFN-related signals occupied a lot of proportion in a"/>
  <result pre="a lot of proportion in a variety of signal categories." exact="Type I" post="IFNs are the major line of host defense against"/>
  <result pre="major line of host defense against viruses and other microorganisms." exact="Viral" post="RNA activates signaling cascades through a number of pattern"/>
  <result pre="including RIG-Iâ€&quot;MAVS, cGAS-STING, and TLR3/4-TRIF (toll-like receptors 3 and 4).24,25" exact="Type I" post="IFNs are regulated by IFN regulatory factor 3 (IRF-3),"/>
  <result pre="and several intracellular signaling molecules, which are activated by PRRs.21" exact="Type I" post="IFNs are essential for immune defense against viruses by"/>
  <result pre="genes and then suppressing the replication and spread of virus.20" exact="Type I" post="IFNs activate key components of the innate and adaptive"/>
  <result pre="antiviral and immune-modulating functions.21 The most studied members of the" exact="Type I" post="family of interferons are the multiple IFNÎ± and IFNÎ²."/>
  <result pre="a transcription factor of IFN-Î². In the early phase of" exact="viral infection," post="IÎºB kinase Îµ and TANK-binding kinase 1 (TBK-1) phosphorylate"/>
  <result pre="into the nucleus and the initiation of the transcription of" exact="Type I" post="IFNs.25 Simultaneously, the synthesized IFN-Î² initiates JAK-STAT signaling during"/>
  <result pre="I IFNs.25 Simultaneously, the synthesized IFN-Î² initiates JAK-STAT signaling during" exact="virus infection," post="leading to the phosphorylation of STAT1 and giving rise"/>
  <result pre="antiviral mechanisms of SFJD, we examined the expressions of the" exact="Type I" post="IFN and PRR-related protein phosphorylation. Western blot analysis was"/>
  <result pre="E-treated group were significantly downregulated. Figure 4 Western blot of" exact="Type I" post="IFN-related proteins in the H1N1-infected RAW264.7 cells. For all"/>
  <result pre="The expression level of phosphorylated MAPK, STAT1, and NF-ÎºB and" exact="total" post="IRF3, MAPK, and NF-ÎºB was analyzed by western blot"/>
  <result pre="0.05. Here, key molecules (IRF3, MAPK, and NF-ÎºB) mediating the" exact="Type I" post="IFN response and MAPK/NF-ÎºB signaling pathways were upregulated under"/>
  <result pre="SFJD could mediate the protein phosphorylation levels of the H1N1-induced" exact="Type I" post="IFNs and PRR signaling pathways to enhance its antiviral"/>
  <result pre="viability of H1N1-infected RAW264.7 cells. Further mechanism study reveals that" exact="Type I" post="IFNs and MAPK/NF-ÎºB signaling pathways are involved in the"/>
  <result pre="IFNs and MAPK/NF-ÎºB signaling pathways are involved in the anti-H1N1" exact="infection" post="effects of SFJD. Our study not only provides solid"/>
  <result pre="A; and 35â€&quot;40 min, 50â€&quot;100% A. The mass spectrum was" exact="acquired" post="with a Waters Q-TOF Premier coupled to an electrospray"/>
  <result pre="University of Chinese Medicine. Virus was propagated in the allantoic" exact="cavities" post="of 9 day-old specific-pathogen-free (SPF) chicken embryonated eggs. After"/>
  <result pre="calculated by the Reedâ€&quot;Muench method and expressed as median tissue" exact="infectious" post="doses (TCID50). The murine macrophage cell line (RAW264.7) was"/>
  <result pre="a membrane filter (0.22 Î¼m) for UPLC-TOF MS analysis. A" exact="total" post="of 94 compounds of SFJD were identified and fingerprint"/>
  <result pre="Tween-20 in Trisbuffered saline (TBST) and then incubated with the" exact="primary" post="antibody at 4 Â°C overnight. After washing three times"/>
  <result pre="global protein changes in different treatment groups during the H1N1" exact="infection" post="in RAW264.7 cells (PDF) (XLSX) Supplementary Material LINK ao0c01545_si_001.pdf"/>
  <result pre="LevyM. A.; StoreygardA.; BalkD.; GittlemanJ. L.; DaszakP.Global trends in emerging" exact="infectious diseases." post="Nature2008, 451, 990â€&quot;993. 10.1038/nature06536.18288193 McClellanK.; PerryC. M.Oseltamivir. Drugs2001, 61,"/>
  <result pre="M.; HayA. J.; GamblinS. J.; SkehelJ. J.The structure of H5N1" exact="avian influenza" post="neuraminidase suggests new opportunities for drug design. Nature2006, 443,"/>
  <result pre="WongC. C. L.Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an" exact="Acute" post="Lung Injury Animal Model Using Quantitative Proteomics Technology. J."/>
  <result pre="GaoJ.; HouY.; JiangM.; ZhangT.; BaiG.Anti-inflammatory effects of Shufengjiedu capsule for" exact="upper respiratory infection" post="via the ERK pathway. Biomed. Pharmacother.2017, 94, 758â€&quot;766. 10.1016/j.biopha.2017.07.118.28802227"/>
  <result pre="HouY.; JiangM.; ZhangT.; BaiG.Anti-inflammatory effects of Shufengjiedu capsule for upper" exact="respiratory" post="infection via the ERK pathway. Biomed. Pharmacother.2017, 94, 758â€&quot;766."/>
  <result pre="JiangM.; ZhangT.; BaiG.Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory" exact="infection" post="via the ERK pathway. Biomed. Pharmacother.2017, 94, 758â€&quot;766. 10.1016/j.biopha.2017.07.118.28802227"/>
  <result pre="of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced" exact="acute" post="exacerbation of chronic obstructive pulmonary disease. Biomed. Pharmacother.2020, 121,"/>
  <result pre="Capsule and oseltamivir in influenza A viral-induced acute exacerbation of" exact="chronic" post="obstructive pulmonary disease. Biomed. Pharmacother.2020, 121, 10965210.1016/j.biopha.2019.109652.31734578 SawakamiT.; XiaJ.;"/>
  <result pre="oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive" exact="pulmonary" post="disease. Biomed. Pharmacother.2020, 121, 10965210.1016/j.biopha.2019.109652.31734578 SawakamiT.; XiaJ.; SongP.Researchers of"/>
  <result pre="pulmonary disease. Biomed. Pharmacother.2020, 121, 10965210.1016/j.biopha.2019.109652.31734578 SawakamiT.; XiaJ.; SongP.Researchers of" exact="chronic" post="obstructive pulmonary disease gathered at the 2017 Japan-China Joint"/>
  <result pre="Biomed. Pharmacother.2020, 121, 10965210.1016/j.biopha.2019.109652.31734578 SawakamiT.; XiaJ.; SongP.Researchers of chronic obstructive" exact="pulmonary" post="disease gathered at the 2017 Japan-China Joint Medical Workshop"/>
  <result pre="Pharmacother.2020, 121, 10965210.1016/j.biopha.2019.109652.31734578 SawakamiT.; XiaJ.; SongP.Researchers of chronic obstructive pulmonary" exact="disease" post="gathered at the 2017 Japan-China Joint Medical Workshop on"/>
  <result pre="of chronic obstructive pulmonary disease gathered at the 2017 Japan-China" exact="Joint" post="Medical Workshop on Aging and Health. BioSci. Trends2017, 11,"/>
  <result pre="EnomotoN.; WatanabeM.Expressional screening of interferon-stimulated genes for antiviral activity against" exact="hepatitis C" post="virus replication. J. Viral. Hepat.2006, 13, 690â€&quot;700. 10.1111/j.1365-2893.2006.00732.x.16970601 MancusoG.;"/>
  <result pre="MengZ.; YanC.; DengQ.; GaoD.-f.; NiuX.-l.Curcumin inhibits LPS-induced inflammation in rat" exact="vascular" post="smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-kappaB pathways."/>
  <result pre="DengQ.; GaoD.-f.; NiuX.-l.Curcumin inhibits LPS-induced inflammation in rat vascular smooth" exact="muscle" post="cells in vitro via ROS-relative TLR4-MAPK/NF-kappaB pathways. Acta Pharmacol."/>
  <result pre="34, 901â€&quot;911. 10.1038/aps.2013.24.23645013 PerryA. K.; ChenG.; ZhengD.; TangH.; ChengG.The host" exact="type I" post="interferon response to viral and bacterial infections. Cell Res.2005,"/>
  <result pre="ChenG.; ZhengD.; TangH.; ChengG.The host type I interferon response to" exact="viral" post="and bacterial infections. Cell Res.2005, 15, 407â€&quot;422. 10.1038/sj.cr.7290309.15987599 SchogginsJ."/>
  <result pre="TangH.; ChengG.The host type I interferon response to viral and" exact="bacterial infections." post="Cell Res.2005, 15, 407â€&quot;422. 10.1038/sj.cr.7290309.15987599 SchogginsJ. W.Interferon-stimulated genes: roles"/>
  <result pre="Cell Res.2005, 15, 407â€&quot;422. 10.1038/sj.cr.7290309.15987599 SchogginsJ. W.Interferon-stimulated genes: roles in" exact="viral" post="pathogenesis. Curr. Opin. Virol.2014, 6, 40â€&quot;46. 10.1016/j.coviro.2014.03.006.24713352 TakeuchiO.; AkiraS.Pattern"/>
  <result pre="LinE.; LinY.-L.Blocking of the alpha interferon-induced Jak-Stat signaling pathway by" exact="Japanese encephalitis" post="virus infection. J. Virol.2004, 78, 9285â€&quot;9294. 10.1128/jvi.78.17.9285-9294.2004.15308723 PalmaJ. P.;"/>
  <result pre="LinY.-L.Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese" exact="encephalitis" post="virus infection. J. Virol.2004, 78, 9285â€&quot;9294. 10.1128/jvi.78.17.9285-9294.2004.15308723 PalmaJ. P.;"/>
  <result pre="of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis" exact="virus infection." post="J. Virol.2004, 78, 9285â€&quot;9294. 10.1128/jvi.78.17.9285-9294.2004.15308723 PalmaJ. P.; KwonD.; ClipstoneN."/>
  <result pre="PalmaJ. P.; KwonD.; ClipstoneN. A.; KimB. S.Infection with Theilerâ€™s murine" exact="encephalomyelitis" post="virus directly induces proinflammatory cytokines in primary Astrocytes via"/>
  <result pre="with Theilerâ€™s murine encephalomyelitis virus directly induces proinflammatory cytokines in" exact="primary" post="Astrocytes via NF-kappa B activation: Potential role for the"/>
  <result pre="via NF-kappa B activation: Potential role for the initiation of" exact="demyelinating disease." post="J. Virol.2003, 77, 6322â€&quot;6331. 10.1128/jvi.77.11.6322-6331.2003.12743289 IwasakiA.; PillaiP. S.Innate immunity"/>
  <result pre="Virol.2003, 77, 6322â€&quot;6331. 10.1128/jvi.77.11.6322-6331.2003.12743289 IwasakiA.; PillaiP. S.Innate immunity to influenza" exact="virus infection." post="Nat. Rev. Immunol.2014, 14, 315â€&quot;328. 10.1038/nri3665.24762827 KawaiT.; AkiraS.The role"/>
  <result pre="protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the" exact="type I" post="interferon receptor. Cell Host Microbe2009, 5, 72â€&quot;83. 10.1016/j.chom.2008.11.008.19154989"/>
 </snippets>
</snippetsTree>
